vs
信安金融集团（PFG）与硕腾（ZTS）财务数据对比。点击上方公司名可切换其他公司
信安金融集团的季度营收约是硕腾的1.9倍（$4.6B vs $2.4B），硕腾净利率更高（25.3% vs 11.3%，领先14.0%），硕腾同比增速更快（3.0% vs -3.7%），过去两年信安金融集团的营收复合增速更高（6.3% vs 4.4%）
信安金融集团（股票代码：PFG）是总部位于美国艾奥瓦州得梅因的全球性金融服务企业，核心业务涵盖投资管理、保险服务两大板块，在全球多个区域开展业务，为机构客户和个人用户提供专业定制化的金融解决方案，在行业内拥有较高知名度。
硕腾是全球规模最大的动物保健制药企业，专注于宠物与家畜用药品、疫苗的研发和生产，前身为制药巨头辉瑞旗下的动物保健业务板块，辉瑞剥离多数股权后成为完全独立的企业。目前公司产品直销约45个国家，在全球超过100个国家和地区销售，海外业务占总营收的50%左右。
PFG vs ZTS — 直观对比
营收规模更大
PFG
是对方的1.9倍
$2.4B
营收增速更快
ZTS
高出6.7%
-3.7%
净利率更高
ZTS
高出14.0%
11.3%
两年增速更快
PFG
近两年复合增速
4.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.6B | $2.4B |
| 净利润 | $517.0M | $603.0M |
| 毛利率 | — | 70.2% |
| 营业利润率 | — | 31.9% |
| 净利率 | 11.3% | 25.3% |
| 营收同比 | -3.7% | 3.0% |
| 净利润同比 | -42.9% | 3.8% |
| 每股收益（稀释后） | $2.30 | $1.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PFGZTS
| Q4 25 | $4.6B | $2.4B | ||
| Q3 25 | $3.7B | $2.4B | ||
| Q2 25 | $3.7B | $2.5B | ||
| Q1 25 | $3.7B | $2.2B | ||
| Q4 24 | $4.8B | $2.3B | ||
| Q3 24 | $3.0B | $2.4B | ||
| Q2 24 | $4.3B | $2.4B | ||
| Q1 24 | $4.1B | $2.2B |
净利润PFGZTS
| Q4 25 | $517.0M | $603.0M | ||
| Q3 25 | $213.8M | $721.0M | ||
| Q2 25 | $406.2M | $718.0M | ||
| Q1 25 | $48.1M | $631.0M | ||
| Q4 24 | $905.4M | $581.0M | ||
| Q3 24 | $-220.0M | $682.0M | ||
| Q2 24 | $353.1M | $624.0M | ||
| Q1 24 | $532.5M | $599.0M |
毛利率PFGZTS
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 71.5% | ||
| Q2 25 | — | 73.6% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 71.7% | ||
| Q1 24 | — | 70.6% |
营业利润率PFGZTS
| Q4 25 | — | 31.9% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 36.7% | ||
| Q1 25 | — | 36.5% | ||
| Q4 24 | — | 31.6% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 33.0% | ||
| Q1 24 | — | 34.1% |
净利率PFGZTS
| Q4 25 | 11.3% | 25.3% | ||
| Q3 25 | 5.8% | 30.0% | ||
| Q2 25 | 11.1% | 29.2% | ||
| Q1 25 | 1.3% | 28.4% | ||
| Q4 24 | 19.1% | 25.1% | ||
| Q3 24 | -7.3% | 28.6% | ||
| Q2 24 | 8.2% | 26.4% | ||
| Q1 24 | 13.1% | 27.4% |
每股收益（稀释后）PFGZTS
| Q4 25 | $2.30 | $1.37 | ||
| Q3 25 | $0.95 | $1.63 | ||
| Q2 25 | $1.79 | $1.61 | ||
| Q1 25 | $0.21 | $1.41 | ||
| Q4 24 | $3.92 | $1.29 | ||
| Q3 24 | $-0.95 | $1.50 | ||
| Q2 24 | $1.49 | $1.37 | ||
| Q1 24 | $2.22 | $1.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.4B | — |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $11.9B | $3.3B |
| 总资产 | $341.4B | $15.5B |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资PFGZTS
| Q4 25 | $4.4B | — | ||
| Q3 25 | $5.1B | $2.1B | ||
| Q2 25 | $3.7B | $1.4B | ||
| Q1 25 | $3.9B | $1.7B | ||
| Q4 24 | $4.2B | $2.0B | ||
| Q3 24 | $6.2B | $1.7B | ||
| Q2 24 | $4.8B | $1.6B | ||
| Q1 24 | $4.2B | $2.0B |
总债务PFGZTS
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.9B | — | ||
| Q1 24 | $3.9B | — |
股东权益PFGZTS
| Q4 25 | $11.9B | $3.3B | ||
| Q3 25 | $11.7B | $5.4B | ||
| Q2 25 | $11.4B | $5.0B | ||
| Q1 25 | $11.2B | $4.7B | ||
| Q4 24 | $11.1B | $4.8B | ||
| Q3 24 | $11.2B | $5.2B | ||
| Q2 24 | $11.0B | $5.0B | ||
| Q1 24 | $11.2B | $5.1B |
总资产PFGZTS
| Q4 25 | $341.4B | $15.5B | ||
| Q3 25 | $334.5B | $15.2B | ||
| Q2 25 | $323.1B | $14.5B | ||
| Q1 25 | $313.0B | $14.1B | ||
| Q4 24 | $313.7B | $14.2B | ||
| Q3 24 | $322.9B | $14.4B | ||
| Q2 24 | $308.8B | $14.2B | ||
| Q1 24 | $308.7B | $14.3B |
负债/权益比PFGZTS
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.39× | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7B | $893.0M |
| 自由现金流经营现金流 - 资本支出 | — | $732.0M |
| 自由现金流率自由现金流/营收 | — | 30.7% |
| 资本支出强度资本支出/营收 | — | 6.7% |
| 现金转化率经营现金流/净利润 | 3.37× | 1.48× |
| 过去12个月自由现金流最近4个季度 | — | $2.3B |
8季度趋势，按日历期对齐
经营现金流PFGZTS
| Q4 25 | $1.7B | $893.0M | ||
| Q3 25 | $1.0B | $938.0M | ||
| Q2 25 | $811.9M | $486.0M | ||
| Q1 25 | $977.3M | $587.0M | ||
| Q4 24 | $1.5B | $905.0M | ||
| Q3 24 | $1.1B | $951.0M | ||
| Q2 24 | $1.4B | $502.0M | ||
| Q1 24 | $584.2M | $595.0M |
自由现金流PFGZTS
| Q4 25 | — | $732.0M | ||
| Q3 25 | — | $805.0M | ||
| Q2 25 | — | $308.0M | ||
| Q1 25 | — | $438.0M | ||
| Q4 24 | — | $689.0M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $455.0M |
自由现金流率PFGZTS
| Q4 25 | — | 30.7% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | — | 32.8% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 20.8% |
资本支出强度PFGZTS
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 6.4% |
现金转化率PFGZTS
| Q4 25 | 3.37× | 1.48× | ||
| Q3 25 | 4.70× | 1.30× | ||
| Q2 25 | 2.00× | 0.68× | ||
| Q1 25 | 20.32× | 0.93× | ||
| Q4 24 | 1.61× | 1.56× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | 4.05× | 0.80× | ||
| Q1 24 | 1.10× | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PFG
| Segment Retirement And Income Solutions | $1.6B | 36% |
| Segment Benefits And Protection | $1.1B | 23% |
| Other | $582.8M | 13% |
| Segment Principal Asset Management | $465.6M | 10% |
| Subsegment Investment Management | $449.4M | 10% |
| Administrative Service | $152.2M | 3% |
| Subsegment International Pension | $91.2M | 2% |
| Segment Corporate | $73.0M | 2% |
| Subsegment Life Insurance | $26.1M | 1% |
| Financial Service Other | $25.1M | 1% |
| Residential Mortgage | $7.4M | 0% |
| Subsegment Specialty Benefits | $3.7M | 0% |
| Deposit Account | $3.4M | 0% |
| Commission Income | $1.8M | 0% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
